• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconPharmaceutical Industry

Pharmaceutical Industry

Page 90 of 100
Johnson & Johnson Products Ahead Of Earnings
HealthJohnson & Johnson struggles to boost drug sales even as profits gain
By Laura LorenzettiOctober 13, 2015
Eli Lilly & Co's Zyprexa schizophrenia drug is pictured in a
FinanceEli Lilly adds one more to roster of failed heart drugs, and it won’t be the last
By Laura LorenzettiOctober 12, 2015
General Views of Eli Lilly & Co.
HealthWhy drug maker Eli Lilly’s stock price is down big today
By John KellOctober 12, 2015
Hedge fund manager Bill Ackman
FinanceThe strange thing about Bill Ackman’s defense of Valeant’s drug prices
By Stephen GandelOctober 7, 2015
AmerisourceBergen pays $2.58 billion to buy PharMEDium
HealthAmerisourceBergen pays $2.58 billion to buy PharMEDium
By Laura LorenzettiOctober 6, 2015
Symbolic - biotechnology - genetic engineering
HealthTPP trade deal: Even more bad news for biotech industry
By Laura LorenzettiOctober 5, 2015
Japan Scenics
HealthThis Japanese pufferfish could be the ultimate painkiller
By Laura LorenzettiSeptember 30, 2015
Why drug price controversy is great news for this hedge fund manager
FinanceWhy drug price controversy is great news for this hedge fund manager
By Jen WiecznerSeptember 30, 2015
The drug price conundrum: a Q&A with Memorial Sloan Kettering’s Dr. Peter B. Bach
HealthThe drug price conundrum: a Q&A with Memorial Sloan Kettering’s Dr. Peter B. Bach
By Laura LorenzettiSeptember 29, 2015
J. Michael Pearson, Chairman of the board and Chief Executive Officer of Valeant Pharmaceuticals International Inc., waits for the start of their annual general meeting in Laval, Quebec
HealthBiotech stocks dive as lawmakers take aim at Valeant for drug price hikes
By Laura LorenzettiSeptember 28, 2015
GOP Candidate For President Donald Trump Campaigns In Columbia, South Carolina
LeadershipDonald Trump on drug price-raising CEO: ‘Spoiled brat’
By Laura LorenzettiSeptember 24, 2015
Inside Teva Pharmaceuticals Headquarters
HealthHere are the 5 drug classes with the biggest price gains
By Laura LorenzettiSeptember 23, 2015
MSMB Capital Management CIO Martin Shkreli
HealthTuring backs down on Daraprim drug pricing
By TIMESeptember 23, 2015
157934085
HealthDoctors respond to Turing drug price hike: ‘It’s scare mongering’
By Laura LorenzettiSeptember 22, 2015
HIllary Rodham Clinton
HealthHillary Clinton releases health plan that aims to combat skyrocketing drug costs
By Laura LorenzettiSeptember 22, 2015
1...
  • 88
  • 89
  • 90
  • 91
  • 92
...100
Most Popular
Future of Work
'Employers are increasingly turning to degree and GPA' in hiring: Recruiters retreat from ‘talent is everywhere,’ double down on top collegesplaceholder alt text
By Jake AngeloMay 9, 2026
Politics
Ted Cruz says the quiet part out loud: Trump accounts are Social Security personal accounts as GOP senator reveals 'dirty little secret'placeholder alt text
By Jason MaMay 9, 2026
Success
Red flag test: former CEO explains why he rejects job candidates who say they can start right awayplaceholder alt text
By Orianna Rosa RoyleMay 9, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.